GAUCHER DISEASE TREATMENT MARKET ANALYSIS

Gaucher Disease Treatment Market, by Disease Type (Type 1 Gaucher disease, Type 2 Gaucher Disease, and Type 3 Gaucher Disease), by Therapy Type (Enzyme Replacement Therapy (ERT) and Substrate Reduction Therapy (SRT)), by Distribution Channel (Hospitals, Retail Pharmacies, and Online Pharmacies) and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI1225
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Key players operating in global Gaucher disease treatment market include Genzyme Corporation, Pfizer, Inc., Shire Human Genetics Therapies, Inc., and Actelion Pharmaceuticals Ltd. (acquired by Johnson & Johnson in June 2017). There are various drugs in pipeline of companies such as Lixte Biotechnology Holdings Inc, JCR Pharmaceuticals Co Ltd, Pharming Group NV and Orphazyme ApS, for Gaucher disease treatment.